These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 861050)

  • 1. The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia.
    Smith CS; Chinn S; Watts RW
    Biochem Pharmacol; 1977 May; 26(9):847-52. PubMed ID: 861050
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of phenylbutazone and oxyphenbutazone on DNA synthesis in normal human bone marrow cells in vitro.
    Dewse CD; Potter CG
    J Pharm Pharmacol; 1975 Jul; 27(7):523-6. PubMed ID: 239158
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of DNA synthesis in cultured human lymphocytes by phenylbutazone and oxyphenbutazone.
    Dewse CD
    J Pharm Pharmacol; 1976 Jul; 28(7):596-8. PubMed ID: 8620
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
    Chaplin S
    Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of therapeutic concentrations of phenylbutazone on granulocyte function.
    Solberg CO
    Acta Pathol Microbiol Scand B; 1975 Apr; 83(2):100-2. PubMed ID: 1155108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells.
    Aymard JP; Rouveix B; Ferry R; Janot C; May T; Legras B; Streiff F
    Acta Haematol; 1989; 82(1):40-2. PubMed ID: 2505473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of D-glucuronic acid on the regenerative processes of granulomonocytopoiesis in cytostatic-induced myelodepression].
    Gol'dberg ED; Dygaĭ AM; Karpova GV; Simanina EV; Khlusov IA; Shakhov VP; Agafonov VI
    Eksp Klin Farmakol; 1993; 56(6):25-8. PubMed ID: 8111290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.
    Rhodes EG; Ball J; Franklin IM
    Br Med J (Clin Res Ed); 1986 Mar; 292(6522):717-8. PubMed ID: 3082409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide-induced agranulocytosis with reversible myeloid sensitivity.
    Nelson JC; Lutton JD; Fass AE
    Am J Hematol; 1984; 17(4):427-32. PubMed ID: 6333812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A contribution on the antiproteolytic activity quality of phenylbutazone, oxyphenbutazone and sodium salicylate].
    Mörsdorf K; Marten S; Puchert I
    Arzneimittelforschung; 1968 Dec; 18(12):1516-20. PubMed ID: 5756244
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the effect of phenylbutazone inj. ketazone inj. and Kenalog 40 inj. in relation to modification of the pyknotic disintegration of leukocyte nuclei].
    Zdichynec
    Fysiatr Revmatol Vestn; 1978 Apr; 56(2):95-8. PubMed ID: 565330
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenylbutazone and oxyphenbutazone: time to call a halt.
    Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interactions of phenylbutazone and oxyphenbutazone with glymidine (author's transl)].
    Held M; Scheible G
    Arzneimittelforschung; 1981; 31(6):1036-8. PubMed ID: 6455124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocytic colony forming cells in vitro: I. Patients with drug induced agranulocytosis.
    Heit W; Kern P; Heimpel H; Kubanek B
    Blut; 1977 May; 34(5):403-5. PubMed ID: 301414
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone.
    Pandhi RK; Dedi TR
    Arch Dermatol; 1975 Jan; 111(1):131. PubMed ID: 1119818
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-induced bone marrow failure].
    Iordanova E; Khadzhieva ZH
    Vutr Boles; 1987; 26(2):86-90. PubMed ID: 3604203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of in vitro studies of drug-induced agranulocytosis. Report of 14 cases.
    Parent-Massin DM; Sensébé L; Léglise MC; Guern G; Berthou C; Riché C; Abgrall JF
    Drug Saf; 1993 Dec; 9(6):463-9. PubMed ID: 8129866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.